Drug-resistant epilepsy: Definition, pathophysiology, and management
- PMID: 37597343
- DOI: 10.1016/j.jns.2023.120766
Drug-resistant epilepsy: Definition, pathophysiology, and management
Abstract
There are currently >51 million people with epilepsy (PWE) in the world and every year >4.9 million people develop new-onset epilepsy. The cornerstone of treatment in PWE is drug therapy with antiseizure medications (ASMs). However, about one-third of PWE do not achieve seizure control and do not respond well to drug therapy despite the use of appropriate ASMs [drug-resistant epilepsy (DRE)]. The aims of the current narrative review are to discuss the definition of DRE, explain the biological underpinnings and clinical biomarkers of this condition, and finally to suggest practical management strategies to tackle this issue appropriately, in a concise manner.
Keywords: Drug resistance; Epilepsy; Seizure; Treatment.
Copyright © 2023 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest No funding was received for this review. This review was presented at the 5th Qatar International Epilepsy Course in January 12th, 2023 by the authors. We thank Hamad Medical Corporation, Neurosciences and Medical Education Departments for supporting this event.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
